Home | Welcome to Contract Pharma   
Last Updated Friday, December 19 2014



The engineering of an antibody protein sequence to make it more human like and less antigenic during therapeutic use.

blog comments powered by Disqus

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On